Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Wingard

Showing results (131-140 of 172) with videos related to

Pageof 18
Sort By:
Bone Marrow Transplantation|January 26, 2006
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT)J D Rizzo, J R Wingard, A Tichelli, et al.
Gastroenterology|August 1, 1990
Orthotopic liver transplantation for graft-versus-host disease following bone marrow transplantationD F Rhodes, W M Lee, J R Wingard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1990
Allogeneic bone marrow transplantation for patients with high-risk acute lymphoblastic leukemiaJ R Wingard, S Piantadosi, G W Santos, et al.
Bone Marrow Transplantation|July 1, 1997
Lack of interaction between tacrolimus (FK506) and methotrexate in bone marrow transplant recipientsJ R Wingard, R A Nash, V Ratanatharathorn, et al.
Transplantation Proceedings|February 1, 1995
FK 506-based immunosuppression for prevention of graft versus host disease after unrelated donor marrow transplantationJ W Fay, R A Nash, J R Wingard, et al.
Bone Marrow Transplantation|March 1, 1991
Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow graftsS D Rowley, S Piantadosi, D C Marcellus, et al.
Blood|September 1, 1989
Predictors of death from chronic graft-versus-host disease after bone marrow transplantationJ R Wingard, S Piantadosi, G B Vogelsang, et al.
Acta Haematologica|January 1, 1987
Allogeneic, syngeneic and autologous marrow transplantation in the acute leukemias and lymphomas--Baltimore experiencesG W Santos, R Saral, W H Burns, et al.
Blood|May 1, 1988
Cytomegalovirus infection after autologous bone marrow transplantation with comparison to infection after allogeneic bone marrow transplantationJ R Wingard, D Y Chen, W H Burns, et al.
The New England Journal of Medicine|April 16, 1992
Thalidomide for the treatment of chronic graft-versus-host diseaseG B Vogelsang, E R Farmer, A D Hess, et al.
Pageof 18

Showing results (131-140 of 172) with videos related to

Sort By:
Pageof 18
Bone Marrow Transplantation|January 26, 2006
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT)J D Rizzo, J R Wingard, A Tichelli, et al.
Gastroenterology|August 1, 1990
Orthotopic liver transplantation for graft-versus-host disease following bone marrow transplantationD F Rhodes, W M Lee, J R Wingard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1990
Allogeneic bone marrow transplantation for patients with high-risk acute lymphoblastic leukemiaJ R Wingard, S Piantadosi, G W Santos, et al.
Bone Marrow Transplantation|July 1, 1997
Lack of interaction between tacrolimus (FK506) and methotrexate in bone marrow transplant recipientsJ R Wingard, R A Nash, V Ratanatharathorn, et al.
Transplantation Proceedings|February 1, 1995
FK 506-based immunosuppression for prevention of graft versus host disease after unrelated donor marrow transplantationJ W Fay, R A Nash, J R Wingard, et al.
Bone Marrow Transplantation|March 1, 1991
Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow graftsS D Rowley, S Piantadosi, D C Marcellus, et al.
Blood|September 1, 1989
Predictors of death from chronic graft-versus-host disease after bone marrow transplantationJ R Wingard, S Piantadosi, G B Vogelsang, et al.
Acta Haematologica|January 1, 1987
Allogeneic, syngeneic and autologous marrow transplantation in the acute leukemias and lymphomas--Baltimore experiencesG W Santos, R Saral, W H Burns, et al.
Blood|May 1, 1988
Cytomegalovirus infection after autologous bone marrow transplantation with comparison to infection after allogeneic bone marrow transplantationJ R Wingard, D Y Chen, W H Burns, et al.
The New England Journal of Medicine|April 16, 1992
Thalidomide for the treatment of chronic graft-versus-host diseaseG B Vogelsang, E R Farmer, A D Hess, et al.
Pageof 18